CR:DOI:7254dfd1e81a7ea8486654594db40a33

{{#scite:
 |reference=sehgal2022ef
 |type=journal-article
 |title=Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India
 |author=Inderpaul S Sehgal;Sahajal Dhooria;Valliappan Muthu;Kuruswamy T Prasad;Ashutosh N Aggarwal;Arunaloke Chakrabarti;Hansraj Choudhary;Mandeep Garg;Ritesh Agarwal|+sep=;
 |journal=The Lancet Infectious Diseases
 |publisher=Elsevier BV
 |year=2022
 |doi=10.1016/s1473-3099(22)00057-3
 |subject=Infectious Diseases
 |issn=1473-3099
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2022-04-15
}}